KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Debt Ratio (2017 - 2020)

Xenon Pharmaceuticals (XENE) has disclosed Debt Ratio for 4 consecutive years, with 0.07 as the latest value for Q1 2020.

  • Quarterly Debt Ratio fell 49.96% to 0.07 in Q1 2020 from the year-ago period, while the trailing twelve-month figure was 0.07 through Mar 2020, down 49.96% year-over-year, with the annual reading at 0.11 for FY2019, N/A changed from the prior year.
  • Debt Ratio for Q1 2020 was 0.07 at Xenon Pharmaceuticals, down from 0.11 in the prior quarter.
  • The five-year high for Debt Ratio was 0.18 in Q1 2018, with the low at 0.07 in Q1 2020.
  • Average Debt Ratio over 4 years is 0.14, with a median of 0.14 recorded in 2019.
  • The sharpest move saw Debt Ratio surged 36.47% in 2019, then tumbled 49.96% in 2020.
  • Over 4 years, Debt Ratio stood at 0.15 in 2017, then fell by 22.65% to 0.11 in 2018, then dropped by 7.8% to 0.11 in 2019, then crashed by 37.14% to 0.07 in 2020.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.07, 0.11, and 0.16 for Q1 2020, Q4 2019, and Q3 2019 respectively.